Chandra Bhagat Pharma Ltd., located in Mumbai, is a pharmaceutical company that was established in 1944. They offer pharmaceutical products globally and specialize in importing and exporting critical care products. Their range of pharmaceutical products includes categories such as anticancer, cardiovascular, and anti-infective. They provide various forms of pharmaceutical products, including oral solids, tablets, capsules, liquid orals, syrup suspension, injections, and more. Chandra Bhagat Pharma ensures that their products come from qualified factories with a minimum of WHO GMP approvals. They have a dedicated regulatory, purchase, and supply team. Throughout their history, Chandra Bhagat Pharma has introduced several products for the first time in India, such as Anti-Tetanus Serum, Oral Poliomyelitis Vaccine, Anti Diphtheria Sera, Streptokinase, Measles Vaccine, Meningococcal A + C Vaccine, and Human Diploid Rabies Vaccine. They have their own marketing team in India and sell over 500 registered trademarks of CBC across the country. The company is known for its well-established brand image and is trusted by doctors. They also supply to hospitals and government institutions. In 2012, Chandra Bhagat Pharma started their export department, which has since flourished and is managed by a dedicated team. They are registered in multiple countries and cater to regulated, unregulated, and semi-regulated markets. The company is available 24/7 through WhatsApp and email, providing fast replies, quality products, and timely deliveries. Chandra Bhagat Pharma is a public listed company on the Bombay Stock Exchange.
Legal Address
323-F Bhagat Bhuvan,, , Dr. Ambedkar Road
Mumbai; Maharashtra;
Postal Code: 400019
Contact Details: Purchase the Chandra Bhagat Pharma Ltd. report to view the information.
Website: http://www.cbcpharma.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service